Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Béatrice Pignolet

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Medecine Sciences : M/S|September 6, 2015
[Migration and pathogenicity of CD8 T cells in central nervous system diseases]Guillaume Martin-Blondel, Béatrice Pignolet, Roland S Liblau
Annals of Neurology|September 5, 2017
ReplyNicolas Fissolo, Béatrice Pignolet, David Brassat, et al.
Cellular and Molecular Life Sciences : CMLS|August 18, 2010
Transgenic mouse models of multiple sclerosisTanja Scheikl, Béatrice Pignolet, Lennart T Mars, et al.
Neurology|September 16, 2020
Author response: Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervalsNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.
Oncoimmunology|March 28, 2017
CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse modelChristina Gebauer, Béatrice Pignolet, Lidia Yshii, et al.
Virology Journal|September 29, 2007
In vitro permissivity of bovine cells for wild-type and vaccinal myxoma virus strainsBéatrice Pignolet, Jean-Luc Duteyrat, Aude Allemandou, et al.
JCI Insight|April 5, 2019
IFN-γ is a therapeutic target in paraneoplastic cerebellar degenerationLidia Yshii, Béatrice Pignolet, Emilie Mauré, et al.
Journal of Virology|February 14, 2004
A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammationChristelle Camus-Bouclainville, Laurence Fiette, Sophie Bouchiha, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2016
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index valuesNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.
Multiple Sclerosis and Related Disorders|August 17, 2018
Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumabRaphaël Bernard-Valnet, Béatrice Pignolet, Damien Biotti, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Medecine Sciences : M/S|September 6, 2015
[Migration and pathogenicity of CD8 T cells in central nervous system diseases]Guillaume Martin-Blondel, Béatrice Pignolet, Roland S Liblau
Annals of Neurology|September 5, 2017
ReplyNicolas Fissolo, Béatrice Pignolet, David Brassat, et al.
Cellular and Molecular Life Sciences : CMLS|August 18, 2010
Transgenic mouse models of multiple sclerosisTanja Scheikl, Béatrice Pignolet, Lennart T Mars, et al.
Neurology|September 16, 2020
Author response: Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervalsNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.
Oncoimmunology|March 28, 2017
CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse modelChristina Gebauer, Béatrice Pignolet, Lidia Yshii, et al.
Virology Journal|September 29, 2007
In vitro permissivity of bovine cells for wild-type and vaccinal myxoma virus strainsBéatrice Pignolet, Jean-Luc Duteyrat, Aude Allemandou, et al.
JCI Insight|April 5, 2019
IFN-γ is a therapeutic target in paraneoplastic cerebellar degenerationLidia Yshii, Béatrice Pignolet, Emilie Mauré, et al.
Journal of Virology|February 14, 2004
A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammationChristelle Camus-Bouclainville, Laurence Fiette, Sophie Bouchiha, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2016
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index valuesNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.
Multiple Sclerosis and Related Disorders|August 17, 2018
Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumabRaphaël Bernard-Valnet, Béatrice Pignolet, Damien Biotti, et al.
Pageof 4